An interventional study of Nurse-Led Home Visit-Based Diabetes Education and Nurse-Led Telephone-Supported Diabetes Education in Type 2 Diabetes Mellitus, sponsored by Saglik Bilimleri Universitesi. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 342 studies in Diabetes Mellitus, Type 2 with a site in Turkey — 62 open to participants now, 72 under way, 12 of them phase 3. Diabetes Mellitus, Type 2 · Turkey.
Among the 342 studies in Diabetes Mellitus, Type 2 with a site in Turkey, this one is the 143rd largest by planned enrollment of the 266 interventional ones that give a count, is one of 46 that started in 2026, is one of 150 with no phase, reaches primary completion later than 42 of the 71 other live ones, and was the 342nd registered.
10,396 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →62 of the 342 studies in Diabetes Mellitus, Type 2 with a site in Turkey are open now. Recruiting first, the newest first:
Pamukkale University · Sites in Turkey
Ages 18–65 · Women only
Hatice Zehra FERHATLAR · Sites in Turkey
Ages 18–65
Ankara Medipol University · Sites in Turkey
Ages 18–74
AstraZeneca · Sites in Turkey, United States, Argentina and 8 more countries
Ages 18+
Novo Nordisk A/S · Sites in Turkey, United States, Argentina and 13 more countries
Ages 45+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 880 Diabetes Mellitus, Type 2 studies recruiting now, 374 (43%) set no upper age limit and 381 (43%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
342 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 85 · Phase 4 28
First in 2002; this study’s year is marked. 46 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 100 across the 266 interventional studies, 118 across the 75 observational. Of the 260 that completed or were terminated, 80 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
129 of 342 have an industry lead sponsor. The 10 most frequent:
Saglik Bilimleri Universitesi is the lead sponsor of 458 studies on the registry; 125 are open to participants now.
Saglik Bilimleri Universitesi has 5 studies filed under Diabetes Mellitus, Type 2 — fewer than ten, so there is no comparison to draw.
24 of the studies in Diabetes Mellitus, Type 2 with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07847294Ankara Medipol UniversityThe Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes | 2026-11 |
| NCT07659925Baskent UniversityPeriodization-Based Strength Exercise Training in İndividuals With Type 2 Diabetes | 2026-11 |
| NCT07734428Istanbul Bilgi UniversityInflammation and Diabetes: Evaluating Antioxidant Levels | 2026-12-30 |
| NCT07649967Selcuk UniversityValidity and Reliability of Mixed Reality-Based Functional Mobility Tests in Type 2 Diabetes | 2026-12-30 |
| NCT07784543Pamukkale UniversityEffects of Aerobic Exercise on Shoulder Pain, Disability, and Ultrasonographic Outcomes in Patients With Type 2 Diabetes Mellitus With Supraspinatus Tendinopathy | 2027-01-25 |
Add all 24 to your calendar (.ics) → With an account.
Among the 342 studies in Diabetes Mellitus, Type 2 with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effects of home visits and telephone-supported education on diabetes knowledge, self-care behaviors, and diabetes-related difficulties in adults with type 2 diabetes attending a family health center in Türkiye. The study will examine whether these educational approaches help participants better understand their diabetes, manage daily self-care, and cope with difficulties related to living with diabetes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Aged 18-65 years. Diagnosed with type 2 diabetes mellitus for at least 6 months. Able to read and understand Turkish. No health condition that impairs cognition or communication. Owns a smartphone. Uses insulin, oral antidiabetic medication, or both. Willing to participate in the study.
Exclusion Criteria:
Pregnancy. Inability to complete the data collection instruments due to a cognitive or psychiatric condition.
Unwillingness to participate in the study.
-
Participants in this group will receive nurse-led diabetes education through home visits. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties.
Behavioral: Nurse-Led Home Visit-Based Diabetes Education
Participants in this group will receive nurse-led, telephone-supported diabetes education. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties.
Behavioral: Nurse-Led Telephone-Supported Diabetes Education
Participants in this group will continue to receive usual care at the family health center. They will not receive the study-specific home visit-based or telephone-supported educational interventions during the study period.
A nurse will provide four structured, face-to-face diabetes education sessions in participants' homes, once weekly for four weeks. Each visit will last approximately 45-60 minutes and use PowerPoint presentations, informational brochures, direct instruction, and questions and answers. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change.
A nurse will provide four structured tele-nursing sessions over one month, once weekly, using telephone calls, video calls, and digital educational materials, including PowerPoint presentations and brochures. Each session will last approximately 15-25 minutes, with additional counseling time when needed. The educational content will be similar to that provided to the home visit group. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. Sessions will reinforce learning, support motivation, and address individual self-care needs.
Change in Diabetes Health-Promoting Self-Care Behaviors
Changes in self-care behaviors will be assessed using the Turkish version of the Diabetes Health-Promoting Self-Care Scale. The scale includes 27 items across seven domains: interpersonal relationships, personal health responsibility, diet, exercise, foot care, blood glucose self-monitoring, and adherence to the recommended regimen. Each item is scored from 1 to 5, giving a total score of 27-135. Higher scores indicate better health-promoting self-care behaviors.
Time frame: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Change in Diabetes Knowledge
Changes in diabetes knowledge will be assessed using the 28-item Adult Diabetes Knowledge Scale developed by Yavuz and Erol. Each correct answer receives 1 point; incorrect and "I do not know" responses receive 0 points. Total scores range from 0 to 28, with higher scores indicating greater diabetes knowledge.
Time frame: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Change in Diabetes-Related Difficulties
Changes in diabetes-related difficulties will be assessed using the 30-item Type 2 Diabetes Strengths and Difficulties Scale developed by Bilgehan and Inkaya. The scale assesses difficulties related to lack of knowledge, individual difficulties, and psychosocial difficulties. Each item is scored from 1 (never experience difficulty) to 5 (always experience difficulty), giving a total score of 30-150. Higher scores indicate greater diabetes-related difficulties.
Time frame: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Plan to share: No — There is currently no plan to share individual participant data with other researchers.
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Mar 2027, 4 months after the start.
Of 2,072 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 4 months is below that.
Counting every sponsor, half of 2,249 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saglik Bilimleri Universitesi →